Funds
BioScience Managers Translation Fund I
Type
Development and commercialisation capital, funding advanced preclinical / phase I-II clinical stage and medical device feasibility/pivotal stage healthcare and biomedical companies.
Region
Investment in Australian public and private companies.
Fund size
A$101 million
Number of investments
To date 4 investments have been made utilising A$14.5 million of committed capital and it is expected that up to 8 to 12 investments in eligible companies can be made.
